This interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints.
Bryce B. Reeve, PhD
Advertisement
Articles by Bryce B. Reeve, PhD
This interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints.
Advertisement
Latest Updated Articles
Patient Quality of Life Endpoints in Oncology Trials, Part IPublished: March 29th 2013 | Updated:
Patient Quality of Life Endpoints in Oncology Trials, Part IIPublished: April 12th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Evaluating the Viability of Antibody Drug Conjugates for Glioblastoma
2
Could Scorpion Venom Component Play a Role in Glioblastoma Management?
3
FDA Approves Abbreviated NDA for Dasatinib Tablets in Leukemia Indications
4
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
5
